An app to educate and change behaviors regarding tick bites
Official title: The Use of Ecological Momentary Assessments to Assess Tick-borne Disease Risk
Run by University of Wisconsin, Madison · NCT06880692 · Data updated 2026-11-12
This study is testing a smartphone app that helps people learn about tick bites and change their habits to prevent tick-borne diseases.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40000 (estimated) |
| Sponsor | University of Wisconsin, Madison Academic / other |
| Locations | 4 sites (Urbana, Illinois and 3 other locations) |
| Status | Recruiting |
| Started | March 31, 2020 |
| Main results expected | July 2027 |
| Study ends | July 2027 |
| Registry record updated | October 29, 2026 |
| Trial ID | NCT06880692 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals willing to engage with the Tick App and complete daily activity logs for a week.
✕Probably not a fit
Patients who are unable or unwilling to commit to logging their activities for the required duration may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of an educational smartphone application designed to change behaviors related to tick encounters and prevent tick-borne diseases. Participants will use the Tick App to log their daily activities and interactions with ticks over a week, providing real-time data on their behaviors and risk factors. The study aims to gather insights into how educational messaging can influence preventive measures against tick bites. Conducted across the United States, particularly in the upper Midwest and Northeast, it will enroll up to 1000 individuals.
Why it matters
Potential benefit: If successful, this app could significantly reduce the incidence of tick bites and tick-borne diseases by promoting effective preventive behaviors.
How similar studies have gone: Previous studies, such as the one conducted in the Netherlands with a similar educational app, have shown positive outcomes in changing user behavior towards tick prevention.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Will to participate in 7 days worth of daily activity logs within the Tick App. * be able and willing to provide informed consent Exclusion Criteria: * Completes less than 7 days worth of daily logs or completes 7+ daily logs but not within 12 months.
Where it's running
-
University of Illinois
Urbana, Illinois, United States Recruiting -
Michigan State University
East Lansing, Michigan, United States Recruiting -
Columbia University
New York, New York, United States Recruiting -
Washington State University
Pullman, Washington, United States Recruiting
Study contacts
- Principal investigator: Susan Paskewitz — University of Wisconsin, Madison
- Study coordinator: Cassie Halvorsen
- Email: chalvorsen2@wisc.edu
- Phone: 608-265-4741
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if informal tick education helps kids ages 6-12
The study tests simple educational activities about ticks for children aged 6 to 12 to see how it changes their attitudes and knowledge.
-
18F-FES PET/MRI to find hidden disease in invasive lobular breast cancer
This study tests whether adding 18F-FES PET/MRI can reveal more disease in lobular breast cancer than standard imaging alone.
-
Share or Not to Share: A Peer-Led Support Program for Caregivers of Autistic Young Adults
A group, peer-led program tests how six virtual sessions can support family caregivers of autistic young adults (ages 18–26) in navigating roles, sharing experiences, and planning for the future.
-
Decision-support tool to aid blood biomarker testing discussions in primary care
A brief tool is being tested to help primary care doctors talk with patients about blood biomarker testing for Alzheimer's disease and support shared decision-making.
-
Durvalumab plus histotripsy for intrahepatic cholangiocarcinoma
This study tests whether adding histotripsy to ongoing durvalumab helps people with advanced intrahepatic cholangiocarcinoma by boosting the immune response and checking safety.
-
Proton Therapy Treatment-Planning Software: Checking How Well RayStation and RayCare Work in Real Care
This study tests whether the RayStation 2025 and RayCare 2025 software upgrades reliably support delivering standard proton therapy to adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.